RxDoctor Payments Data

Louis Difazio

Internal Medicine · Bronx, NYNPI 1245231083

Payments from drug & device makers

$1,968in general payments, 2019–2025

Across 93 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$480
  • Novo Nordisk$287
  • Amgen$225
  • Sanofi-aventis U.S. LLC$149
  • Astellas Pharma US Inc$135
  • Acorda Therapeutics, Inc$96
  • plus $595 from 13 others

What the payments were for

  • Speaking & faculty fees$965%
  • Food & beverage$1,80192%
  • Education$714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,968 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Other internal medicine in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →